Category: Clinical Breakthroughs
-
Common Procedure Does Not Prevent Recurrent Pancreatitis, Trial Finds
A multicenter clinical trial published in JAMA has found that a long-used endoscopic procedure does not prevent recurrent pancreatitis in adults with an anatomic anomaly, challenging decades of conventional wisdom.
-
Non-invasive Approach Predicts Chemotherapy Response in Glioblastoma
Northwestern Medicine scientists have developed a new non-invasive approach that could help better determine which patients with glioblastoma are responding favorably to chemotherapy treatment and inform future treatment plans, according to a recent study published in Nature Communications.
-
Evaluating Treatment of Heart Defects in Preterm Infants
Early pharmacologic treatment of a common congenital heart defect did not improve survival outcomes compared to expectant management in preterm infants, according to a recent clinical trial published in JAMA.
-
Investigating Treatments for Peripheral Artery Disease
A common diabetes medication does not help people with peripheral artery disease (PAD) walk farther, according to results from a major U.S. clinical trial published in JAMA.
-
Experimental Drug Shows Promise for Rare Genetic Disorder
A new experimental therapy has shown encouraging results in treating a rare and progressive lysosomal storage disorder, according to findings from a multi-year clinical trial published in the New England Journal of Medicine.
-
Gestational Diabetes Rose Every Year in the US Since 2016
Gestational diabetes rose every single year in the U.S. from 2016 through 2024, according to a new Northwestern Medicine analysis of more than 12 million U.S. births.
-
Noninvasive Treatment Boosts Immune Response Against Glioblastoma
Northwestern Medicine scientists, along with collaborators from the Washington University School of Medicine, have developed a noninvasive nanomedicine approach that may improve the treatment of glioblastoma, according to a recent study published in the Proceedings of the National Academy of Sciences.
-
Novel Biomarker May Predict Immunotherapy Resistance
Northwestern Medicine scientists have identified a novel biomarker for immune immunotherapy resistance in cancer that may also serve as a potential therapeutic target for patients who don’t respond well to immunotherapy, according to a recent study published in The Journal of Clinical Investigation.
-
New ‘Heart Percentile’ Calculator Helps Young Adults Grasp Their Long-Term Risk
A new Northwestern Medicine study introduces a first-of-its-kind online calculator that uses percentiles to help younger adults forecast and understand their risk of a heart event over the next 30 years.
-
Hormone Therapy Does Not Increase Cardiovascular Disease Risk in Younger Postmenopausal Women
While menopausal hormone therapy increased cardiovascular disease risk in postmenopausal women older than 70 years with vasomotor symptoms, hormone therapy did not significantly affect cardiovascular disease risk in younger postmenopausal women, according to a recent study published in JAMA Internal Medicine.
